Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Drugs like Ozempic, Mounjaro and Saxenda have swept the globe since emerging on the market late last decade, and an estimated 20,000 Australians currently use the drugs for weight loss.

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Saxenda (liraglutide) is a GLP-1 that increases feelings of fullness while decreasing feelings of hunger. It has FDA approval for weight loss, unlike Ozempic, which only has approval for type 2 ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...

Saxenda contains liraglutide, which is a GLP-1 receptor agonist. Liraglutide helps promote weight loss by decreasing appetite and slowing the emptying of the stomach, which promotes feelings of ...

KATIE Price has opened up about her weight loss and insists she’s at her “natural weight” after gaining it on IVF. The star ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it ...